US Food and Drug Administration Launches AI Platform to 'Modernize' Agency
The FDA launched Elsa, a generative AI platform, to enhance internal workflows, reducing task completion time significantly. The rollout was completed ahead of schedule and under budget. Elsa operates securely within the FDA’s GovCloud environment and can summarize adverse event reports, compare drug labels, generate code for databases, and assist inspectors in identifying high-risk sites. All data remains internal, with no training on industry-submitted data. The FDA plans to expand Elsa's capabilities into data automation and generative AI. This initiative aligns with a broader federal push to integrate AI into government operations. At the Bitcoin 2025 conference, Robinhood CEO Vlad Tenev predicted a rise in AI-powered solo ventures, envisioning tokenized, self-operating companies.
